PICOBOO - The Platform Trial In COVID-19 Vaccine BOOsting Study
PICOBOO may sound like a children’s game, but it is continuing to keep the team busy with study visits, welcoming both new participants and our lovely regulars.The team successfully conducted almost 1000 study visits this year, collecting over 691 saliva swabs and 1,815 blood samples! A huge shout out goes to our amazing lab staff who worked endlessly to process and analyse the samples in-house.
Some key highlights for the PICOBOO Study in 2024 include Dr Charlie McLeod presenting early results at the Communicable Diseases and Immunisation Conference held in Brisbane, and the official launch of the study’s very own website.
Recruitment is currently on hold while we wait for the updated JN.1 variant vaccines to become available in Australia. There will be an information webinar for PICOBOO participants in January 2025, and they will contacted before the end of the year with registration details for the event.
Plus we’re excited to invite back our 50+ year-old cohort once the vaccines are accessible!